Date
Event
19
Sep
Regulatory Strategies to De-Risk Medical Device Start-Ups
Thursday, Sep 19, 202411:00—11:50am
Establishing rapport and credibility with a regulatory agency, such as the US Food and Drug Administration (FDA), early in a life sciences company’s journey is a critical factor for its success. It will have an impact on the company’s ability to fundraise, meet milestones, meet budgets, and of course, make its product available to the patients and providers who need it. It’s important to have confidence that the regulatory strategy for your product is innovative and sound, and that when you meet with FDA you know what to say, when to say it, and who to bring.